Stockscreener 앱 받기
6.27
0.32%
-0.02
전일 마감가:
$6.29
열려 있는:
$6.29
하루 거래량:
67,247
Relative Volume:
0.90
시가총액:
$271.33M
수익:
-
순이익/손실:
$-33.65M
주가수익비율:
-1.409
EPS:
-4.45
순현금흐름:
$-20.83M
1주 성능:
+30.62%
1개월 성능:
+46.84%
6개월 성능:
+246.41%
1년 성능:
+205.85%
1일 변동 폭
$6.21
$6.40
1주일 범위
$4.71
$6.47
52주 변동 폭
$1.15
$12.46
미네르바 뉴로사이언스 Stock (NERV) Company Profile
명칭
Minerva Neurosciences Inc
전화
617-600-7373
주소
1500 DISTRICT AVENUE, BURLINGTON, MA
Compare NERV vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NERV
Minerva Neurosciences Inc
|
6.27 | 272.20M | 0 | -33.65M | -20.83M | -4.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
미네르바 뉴로사이언스 Stock (NERV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-06-08 | 재확인 | H.C. Wainwright | Buy |
| 2020-05-14 | 개시 | BTIG Research | Buy |
| 2019-10-02 | 재확인 | Chardan Capital Markets | Buy |
| 2019-09-25 | 개시 | Chardan Capital Markets | Buy |
| 2019-09-18 | 개시 | William Blair | Outperform |
| 2019-05-31 | 개시 | H.C. Wainwright | Buy |
| 2017-09-01 | 개시 | Citigroup | Buy |
| 2017-03-06 | 재개 | Jefferies | Buy |
| 2016-05-12 | 재개 | Jefferies | Buy |
모두보기
미네르바 뉴로사이언스 주식(NERV)의 최신 뉴스
Minerva Neurosciences (NASDAQ:NERV) Stock Price Passes Above 50-Day Moving AverageWhat's Next? - MarketBeat
Minerva Neurosciences Expands Board Amid Fundraising Effort - MSN
Market Wrap: Can Minerva Neurosciences Inc continue delivering strong returnsLayoff News & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Minerva Neurosciences Inc (NERV) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Analysts Have Conflicting Sentiments on These Healthcare Companies: Minerva Neurosciences (NERV) and Verastem (VSTM) - The Globe and Mail
Analysts Have Conflicting Sentiments on These Healthcare Companies: Minerva Neurosciences (NERV), Gossamer Bio (GOSS) and Merck & Company (MRK) - The Globe and Mail
Minerva Neurosciences Spotlights Roluperidone, Lays Out Confirmatory Phase 3 Timeline for Schizophrenia - MarketBeat
Minerva Outlines Confirmatory Phase 3 Plan for Roluperidone - TipRanks
Buyout Rumor: Is Minerva Neurosciences Inc subject to activist investor interest2025 Trading Recap & Real-Time Stock Entry Alerts - baoquankhu1.vn
Is Minerva Neurosciences Inc. subject to activist investor interestRate Cut & Reliable Momentum Entry Alerts - mfd.ru
Stock Analysis: Can Minerva Neurosciences Inc be recession proofJuly 2025 Setups & Momentum Based Trading Ideas - baoquankhu1.vn
Can Minerva Neurosciences Inc. stock double in the next yearJuly 2025 PreEarnings & Community Consensus Picks - mfd.ru
Minerva Neurosciences (NASDAQ:NERV) Share Price Passes Above 50-Day Moving AverageTime to Sell? - MarketBeat
Can Minerva Neurosciences Inc. stock outperform in a bear marketJuly 2025 Weekly Recap & Weekly Top Performers Watchlists - mfd.ru
Minerva Neurosciences to Host Virtual KOL Event to Discuss - GlobeNewswire
Minerva to spotlight potential first drug for key schizophrenia symptoms - Stock Titan
Highs Report: Is Minerva Neurosciences Inc trading at a discountJuly 2025 Price Swings & Fast Moving Market Watchlists - baoquankhu1.vn
Minerva Neurosciences (NASDAQ:NERV) Share Price Passes Above 50 Day Moving AverageWhat's Next? - MarketBeat
Earnings Update: Can Minerva Neurosciences Inc stock double in the next yearFed Meeting & Free Long-Term Investment Growth Plans - baoquankhu1.vn
FOMO Trade: Will Minerva Neurosciences Inc benefit from seasonalityJuly 2025 Movers & Precise Entry and Exit Recommendations - baoquankhu1.vn
Downgrade Watch: Can Minerva Neurosciences Inc stock reach 100 price targetWeekly Investment Summary & Stepwise Trade Signal Guides - Bộ Nội Vụ
Gap Down: Will Minerva Neurosciences Inc 4MNA stock top growth indexes - Bộ Nội Vụ
Street Watch: Is Minerva Neurosciences Inc stock a top pick in earnings seasonVolume Spike & Real-Time Stock Movement Alerts - Bộ Nội Vụ
Wall Street Recap: Why analysts upgrade Minerva Neurosciences Inc. stock2025 Key Highlights & Verified Short-Term Trading Plans - Bộ Nội Vụ
Minerva Neurosciences (NASDAQ:NERV) Cut to Sell at Wall Street Zen - MarketBeat
What risks investors should watch in Minerva Neurosciences Inc. stockWeekly Profit Analysis & Consistent Profit Trade Alerts - Улправда
Is Minerva Neurosciences Inc. (4MNA) stock attractive for dividend growth2025 Trading Volume Trends & Long-Term Capital Growth Strategies - Улправда
Is Minerva Neurosciences Inc. stock attractive for hedge fundsJuly 2025 Technicals & Real-Time Buy Signal Notifications - Улправда
Why Minerva Neurosciences Inc. stock is in analyst buy zone2025 Analyst Calls & Long-Term Investment Growth Plans - Улправда
Is Minerva Neurosciences Inc. stock safe for conservative investorsJuly 2025 Retail & Reliable Trade Execution Plans - Улправда
Why Minerva Neurosciences Inc. stock is rated strong buyJuly 2025 Momentum & Consistent Return Investment Signals - Улправда
Will Minerva Neurosciences Inc. (4MNA) stock top growth indexes2025 Momentum Check & Reliable Momentum Entry Alerts - Улправда
Minerva Neurosciences (NASDAQ:NERV) Upgraded to "Hold" at Wall Street Zen - MarketBeat
Minerva Neurosciences (NASDAQ:NERV) & UCB (OTCMKTS:UCBJY) Head to Head Analysis - Defense World
Working capital per share of Minerva Neurosciences Inc – MUN:4MNA - TradingView — Track All Markets
Gains Recap: Why Minerva Neurosciences Inc stock is in analyst buy zoneProduct Launch & Free Expert Verified Stock Movement Alerts - moha.gov.vn
MSN Money - MSN
Published on: 2025-12-26 01:20:46 - moha.gov.vn
Reviewing Xenetic Biosciences (NASDAQ:XBIO) and Minerva Neurosciences (NASDAQ:NERV) - Defense World
Minerva Neurosciences shareholders approve key governance measures - MSN
Minerva Neurosciences Shareholders Approve Key Governance Measures - TipRanks
Risks Report: Why Minerva Neurosciences Inc. (4MNA) stock stays resilientMarket Activity Summary & Free High Accuracy Swing Entry Alerts - Улправда
Movement Recap: Why analysts upgrade Minerva Neurosciences Inc. stock2025 Growth vs Value & AI Powered Market Entry Ideas - Улправда
How strong is Minerva Neurosciences Inc. stock revenue growthGold Moves & Weekly High Return Forecasts - Улправда
Why analysts upgrade Minerva Neurosciences Inc. stockIndex Update & Risk Controlled Swing Alerts - Улправда
미네르바 뉴로사이언스 (NERV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.12%
0.87%
자본화:
|
볼륨(24시간):